YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) Shares Shorted: Short Interest Up 57.3% in September

YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) was the recipient of a large growth in short interest in the month of September. As of September 15th, there was short interest totaling 80,671 shares, a growth of 57.3% from the August 31st total of 51,284 shares. Based on an average trading volume of 218,763 shares, the short-interest ratio is presently 0.4 days. Approximately 1.5% of the shares of the company are short sold.

YieldMax MRNA Option Income Strategy ETF Trading Down 0.1%

Shares of NYSEARCA:MRNY traded down $0.04 during mid-day trading on Friday, reaching $38.82. The company had a trading volume of 116,461 shares, compared to its average volume of 242,526. The company’s 50-day moving average price is $28.16 and its 200-day moving average price is $21.21. YieldMax MRNA Option Income Strategy ETF has a one year low of $13.60 and a one year high of $42.63.

About YieldMax MRNA Option Income Strategy ETF

The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.